• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Merck & Co (NY:MRK)

    106.78 +0.33 (+0.31%)
    Official Closing Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,208,313
    Open 106.45
    Bid (Size) 106.78 (500)
    Ask (Size) 107.00 (100)
    Prev. Close 106.45
    Today's Range 106.03 - 107.05
    52wk Range 73.31 - 106.95
    Shares Outstanding 2,531,374,696
    Dividend Yield 3.03%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    The Dynavax Turnaround: From Clinical Setbacks to a $2.2 Billion Exit
    As of December 26, 2025, the biotechnology landscape is processing one of the most significant mid-cap acquisitions of the year. Dynavax Technologies Corporation (NASDAQ: DVAX) has transitioned from a... 
    Via PredictStreet
    News headline image
    Merck & Co. Inc. (NYSE:MRK) Emerges as a Top Quality Investing Candidate ↗
    Merck exemplifies quality investing with high ROIC, strong cash flow, and a solid balance sheet, making it a durable long-term healthcare investment candidate. 
    Via Chartmill

    Performance

    YTD
    +7.7%
    +7.7%
    1 Month
    +1.1%
    +1.1%
    3 Month
    +37.6%
    +37.6%
    6 Month
    +35.5%
    +35.5%
    1 Year
    +6.9%
    +6.9%

    More News

    Read More
    News headline image
    Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
    Via MarketMinute
    Topics Economy Intellectual Property
    News headline image
    Barking Back: Why the 'Dogs of the Dow' 4-Stock Play is the Contrarian Bet for 2026
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    The Great Vaccine Consolidation: Sanofi’s $2.2 Billion Strategic Bet on Dynavax Technologies
    Via PredictStreet
    Topics Economy Intellectual Property
    News headline image
    The Vaccine Vanguard: Inside Sanofi’s $2.2 Billion Strategic Bet on Dynavax
    Via PredictStreet
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Prescription for Growth: Why Zoetis and Viatris are Defining Healthcare’s New Winners in 2025
    Via MarketMinute
    Topics Bonds Earnings World Trade
    News headline image
    Moderna (MRNA) Deep-Dive: Navigating the 7.5% Year-End Slide and the Path to a 2028 Recovery
    Via PredictStreet
    Topics Initial Public Offering
    News headline image
    Sanofi’s $2.2 Billion Strategic Pivot: Deconstructing the Dynavax Acquisition and the Future of Specialty Medicine
    Via PredictStreet
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Dynavax Technologies: Analyzing the 39% Surge and Sanofi Acquisition
    Via PredictStreet
    Topics Economy
    News headline image
    Sanofi Acquires Dynavax in $2.2 Billion Christmas Eve Deal, Sending Shares Soaring
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Top 5 US Healthcare Stocks By Market Value ↗
    Via Stocktwits
    Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗
    Via Stocktwits
    Topics Government
    News headline image
    The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025
    Via MarketMinute
    Topics Economy
    News headline image
    SCHD vs. NOBL: Different Paths to Dividend Stability ↗
    Via The Motley Fool
    Topics ETFs
    News headline image
    The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
    Via MarketMinute
    Topics ETFs Economy Intellectual Property
    News headline image
    The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
    Via PredictStreet
    Topics Economy Intellectual Property
    News headline image
    Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
    Via PredictStreet
    Topics Earnings Initial Public Offering Intellectual Property
    News headline image
    Better Buy in 2026: Pfizer or Merck? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗
    Via Stocktwits
    Topics Government World Trade
    News headline image
    Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    Merck & Co. Inc. (NYSE:MRK) Stands Out as a Durable Dividend Stock ↗
    Via Chartmill
    News headline image
    AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report ↗
    Via Stocktwits
    Topics Economy Government
    News headline image
    This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026 ↗
    Via The Motley Fool
    Topics Artificial Intelligence ETFs Economy
    News headline image
    The 2022 Playbook Returns: Why Investors are Building a 'Fortress 2026'
    Via MarketMinute
    Topics Artificial Intelligence Economy World Trade

    Frequently Asked Questions

    Is Merck & Co publicly traded?
    Yes, Merck & Co is publicly traded.
    What exchange does Merck & Co trade on?
    Merck & Co trades on the New York Stock Exchange
    What is the ticker symbol for Merck & Co?
    The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
    What is the current price of Merck & Co?
    The current price of Merck & Co is 106.78
    When was Merck & Co last traded?
    The last trade of Merck & Co was at 12/26/25 04:00 PM ET
    What is the market capitalization of Merck & Co?
    The market capitalization of Merck & Co is 270.30B
    How many shares of Merck & Co are outstanding?
    Merck & Co has 270B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.